Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Tria...

por Cancanelli, Luca, Rivano, Melania, Di Spazio, Lorenzo, Chiumente, Marco, Mengato, Daniele, Messori, Andrea
Publicado 2021

The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibi...

por Di Spazio, Lorenzo, Rivano, Melania, Cancanelli, Luca, Chiumente, Marco, Mengato, Daniele, Messori, Andrea
Publicado 2022

Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments

por Cancanelli, Luca, Rivano, Melania, Di Spazio, Lorenzo, Chiumente, Marco, Mengato, Daniele, Messori, Andrea
Publicado 2023

The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard...

por Messori, Andrea, Rivano, Melania, Cancanelli, Luca, Damuzzo, Vera, Ossato, Andrea, Chiumente, Marco, Mengato, Daniele
Publicado 2022

Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses

por Messori, Andrea, Damuzzo, Vera, Rivano, Melania, Cancanelli, Luca, Di Spazio, Lorenzo, Ossato, Andrea, Chiumente, Marco, Mengato, Daniele
Publicado 2023

The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis

por Damuzzo, Vera, Agnoletto, Laura, Rampazzo, Roberta, Cammalleri, Francesca, Cancanelli, Luca, Chiumente, Marco, Costantino, Stefano, Michielan, Silvia, Milani, Federica, Sartori, Alessia, Rivano, Melania, Mengato, Daniele
Publicado 2021